| DBV TECHNOLOGIES EO -,10 |
| Frankreich |
| Gesundheit |
| FR0010417345 / A1JWB7 |
| DBV (Frankfurt) |
| FRA:DBV, ETR:DBV, DBV:GR |
| - |
| https://dbv-technologies... |
|
DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous patch that delivers allergens like peanut or milk..
>Volltext.. |
| 970.89 Mio. EUR |
| 825.33 Mio. EUR |
| - |
| -120.74 Mio. EUR |
| -131.58 Mio. EUR |
| -0.95 EUR |
| 18.75 Mio. EUR |
| 167.89 Mio. EUR |
| -109.04 Mio. EUR |
| 3.35 |
| - |
| -23.11% |
| - |
| - |
| - |
| - |
| DBV TECHNOLOGIES, DBV TECH |
| 03.04.26 |